{
    "Title": "First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony",
    "URL": "https://doi.org/10.1371/journal.pntd.0000491",
    "Published": "July 28, 2009",
    "Subject_Areas": [
        "Antimony",
        "Lesions",
        "Leishmaniasis",
        "Parasitic diseases",
        "Leishmania",
        "Immune response",
        "Inflammation",
        "Drug therapy"
    ],
    "Authors": {
        "Cesar Miranda-Verastegui": [
            "Universidad Peruana Cayetano Heredia, Lima, Peru"
        ],
        "GianFranco Tulliano": [
            "Universidad Peruana Cayetano Heredia, Lima, Peru"
        ],
        "Theresa W. Gyorkos": [
            "Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Canada"
        ],
        "Wessmark Calderon": [
            "Social Security Hospital ESSALUD-Cusco, Lima, Peru"
        ],
        "Elham Rahme": [
            "Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Canada"
        ],
        "Brian Ward": [
            "Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Canada",
            "Department of Microbiology and Immunology, McGill University, Montreal, Canada"
        ],
        "Maria Cruz": [
            "Social Security Hospital ESSALUD-Cusco, Lima, Peru"
        ],
        "Alejandro Llanos-Cuentas": [
            "Universidad Peruana Cayetano Heredia, Lima, Peru"
        ],
        "Greg Matlashewski": [
            "Department of Microbiology and Immunology, McGill University, Montreal, Canada"
        ]
    }
}